InTrack Investment Management’s Novo Nordisk NVO Stock Holding History

InTrack Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,480	Closed	-$431K	–	116
2025 Q4	$431K	Buy	8,480 +726	+9%	+$37.1K	0.24%	83
2025 Q3	$430K	Buy	7,754 +1,023	+15%	+$59.9K	0.26%	83
2025 Q2	$465K	Buy	+6,731	New	+$458K	0.31%	77
2024 Q4	–	Sell	-4,608	Closed	-$549K	–	120
2024 Q3	$549K	Buy	4,608 +689	+18%	+$91.9K	0.39%	75
2024 Q2	$559K	Buy	3,919 +490	+14%	+$64.9K	0.4%	72
2024 Q1	$440K	Sell	3,429 -1,945	-36%	-$232K	0.33%	94
2023 Q4	$556K	Buy	5,374 +1,100	+26%	+$109K	0.42%	79
2023 Q3	$389K	Sell	4,274 -2,546	-37%	-$224K	0.34%	96
2023 Q2	$552K	Sell	6,820 -600	-8%	-$49K	0.45%	76
2023 Q1	$588K	Buy	+7,420	New	+$526K	0.54%	64

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

InTrack Investment Management's NVO Position: Q1 2026 in Review

InTrack Investment Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 8,480 shares — an estimated $431K sold.

InTrack Investment Management first reported a position in NVO in Q1 2023 and held it in 10 quarters. The position peaked at $588K in Q1 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

InTrack Investment Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
InTrack Investment Management sold 8,480 Novo Nordisk shares in Q1 2026, an estimated $431K.
InTrack Investment Management first reported a position in Novo Nordisk in Q1 2023 and held it in 10 quarters.
InTrack Investment Management's Novo Nordisk position peaked at $588K in Q1 2023.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on InTrack Investment Management's 13F filing for Q1 2026, filed 7 Apr 2026.